Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nucleoside salvage and resistance to antimetabolite anticancer agents.

× No keyword cloud information.

105 in total

1. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors: K M Piafsky; O Borgå
Journal: Clin Pharmacol Ther Date: 1977-11 Impact factor: 6.875

2. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.

Authors: G M Wahl; R A Padgett; G R Stark
Journal: J Biol Chem Date: 1979-09-10 Impact factor: 5.157

3. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.

Authors: J D Moyer; R E Handschumacher
Journal: Cancer Res Date: 1979-08 Impact factor: 12.701

4. Purine nucleotide synthesis in lymphoblasts cultured from normal subjects and a patient with Lesch-Nyhan syndrome.

Authors: A W Wood; M A Becker; J E Seegmiller
Journal: Biochem Genet Date: 1973-07 Impact factor: 1.890

5. Purine nucleotide biosynthesis in gastrointestinal mucosa.

Authors: A M Mackinnon; D J Deller
Journal: Biochim Biophys Acta Date: 1973-08-10

6. Effects of persantin on several transport systems of murine leukemias.

Authors: D Kessel; D C Dodd
Journal: Biochim Biophys Acta Date: 1972-10-23

7. Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-asparate in vivo.

Authors: R K Johnson
Journal: Biochem Pharmacol Date: 1977-01-01 Impact factor: 5.858

8. Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme.

Authors: J A McDonald; W N Kelley
Journal: Science Date: 1971-02-19 Impact factor: 47.728

9. Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095).

Authors: P G Plagemann; M Behrens
Journal: Cancer Res Date: 1976-10 Impact factor: 12.701

10. Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA).

Authors: H N Jayaram; D A Cooney; D T Vistica; S Kariya; R K Johnson
Journal: Cancer Treat Rep Date: 1979-08

10 in total

1. Optimization and evaluation of electroporation delivery of siRNA in the human leukemic CEM cell line.

Authors: Anna Fyrberg; Kourosh Lotfi
Journal: Cytotechnology Date: 2010-10-19 Impact factor: 2.058

Review 2. Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.

Authors: Benigno C Valdez; Borje S Andersson
Journal: Environ Mol Mutagen Date: 2010-07 Impact factor: 3.216

3. Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-β-riboside-induced apoptosis in multiple myeloma cells.

Authors: Carolyne Bardeleben; Sanjai Sharma; Joseph R Reeve; Sara Bassilian; Patrick Frost; Bao Hoang; Yijiang Shi; Alan Lichtenstein
Journal: Mol Cancer Ther Date: 2013-04-12 Impact factor: 6.261

7. Selective potentiation of lometrexol growth inhibition by dipyridamole through cell-specific inhibition of hypoxanthine salvage.

Authors: R N Turner; G W Aherne; N J Curtin
Journal: Br J Cancer Date: 1997 Impact factor: 7.640

8. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.

Authors: N J Curtin; K J Bowman; R N Turner; B Huang; P J Loughlin; A H Calvert; B T Golding; R J Griffin; D R Newell
Journal: Br J Cancer Date: 1999-08 Impact factor: 7.640

Review 9. Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage.

Authors: A R Kinsella; D Smith; M Pickard
Journal: Br J Cancer Date: 1997 Impact factor: 7.640

10. Differences in resistance to 5-fluorouracil as a function of cell cycle delay and not apoptosis.

Authors: M Pickard; C Dive; A R Kinsella
Journal: Br J Cancer Date: 1995-12 Impact factor: 7.640